Skip to main content
Log in

Peroxiredoxin 2 is upregulated in colorectal cancer and contributes to colorectal cancer cells’ survival by protecting cells from oxidative stress

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Peroxiredoxin 2 (Prdx2) is a member of the peroxiredoxin family, which is responsible for neutralizing reactive oxygen species. Prdx2 has been found to be elevated in several human cancer cells and tissues, including colorectal cancer (CRC), and it influences diverse cellular processes involving cells’ survival, proliferation, and apoptosis, which suggests a possible role for Prdx2 in the maintenance of cancer cell. However, the mechanism by which Prdx2 modulates CRC cells’ survival is unknown. The current study aimed to determine the effect of elevated Prdx2 on CRC cells and to further understand the underlying mechanisms. The results of this study showed that Prdx2 was upregulated in CRC tissues compared with the matched noncancer colorectal mucosa tissues and that Prdx2 expression was positively associated with tumor metastasis and the TNM stage. In the LoVo CRC cell line, Prdx2 was upregulated at both the RNA and protein levels compared with the normal FHC colorectal mucosa cell line. In addition, the LoVo CRC cell line was significantly more resistant to hydrogen peroxide (H2O2)-induced apoptosis because of a failure to activate pro-apoptotic pathways in contrast to Prdx2 knockdown cells. Suppression of Prdx2 using a lentiviral vector-mediated Prdx2-specific shRNA in the LoVo cell line restored H2O2 sensitivity. Our results suggested that Prdx2 has an essential role in regulating oxidation-induced apoptosis in CRC cells. Prdx2 may have potential as a therapeutic target in CRC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center Melissa M et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90

    Article  PubMed  Google Scholar 

  2. Hall A, Karplus PA, Poole LB (2009) Typical 2-Cys peroxiredoxins–structures, mechanisms and functions. FEBS J 276(9):2469–2477

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Trachootham D, Lu W, Ogasawara MA, Nilsa RD, Huang P (2008) Redox regulation of cell survival. Antioxid Redox Signal 10(8):1343–1374

    Article  CAS  PubMed  Google Scholar 

  4. Ruckenstuhl C, Büttner S, Carmona-Gutierrez D et al (2009) The Warburg effect suppresses oxidative stress induced apoptosis in a yeast model for cancer. PLoS ONE 4(2):e4592

    Article  PubMed Central  PubMed  Google Scholar 

  5. Lee KW, Lee DJ, Lee JY et al (2011) Peroxiredoxin II restrains DNA damage-induced death in cancer cells by positively regulating JNK-dependent DNA repair. J Biol Chem 286(10):8394–8404

    Article  CAS  PubMed  Google Scholar 

  6. Siddik ZH (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22:7265–7279

    Article  CAS  PubMed  Google Scholar 

  7. Park SA, Choi KS, Bang JH et al (2000) Cisplatin-induced apoptotic cell death in mouse hybrid neurons is blocked by antioxidants through suppression of cisplatin-mediated accumulation of p53 but not of Fas/Fas ligand. J Neurochem 75:946–953

    Article  CAS  PubMed  Google Scholar 

  8. Zhiyu W, Yue C, Neng W et al (2012) Dioscin induces cancer cell apoptosis through elevated oxidative stress mediated by downregulation of peroxiredoxins. Cancer Biol Ther 13(3):138–147

    Article  Google Scholar 

  9. Valdman A, Haggarth L, Cheng L et al (2009) Expression of redox pathway enzymes in human prostatic tissue. Anal Quant Cytol Histol 31(6):367–374

    PubMed  Google Scholar 

  10. Lomnytska MI, Becker S, Hellman K et al (2010) Diagnostic protein marker patterns in squamous cervical cancer. Proteomics Clin Appl 4(1):17–31

    Article  CAS  PubMed  Google Scholar 

  11. Järvelä S, Rantala I, Rodriguez A et al (2010) Specific expression profile and prognostic significance of peroxiredoxins in grade II–IV astrocytic brain tumors. BMC Cancer 10:104

    Article  PubMed Central  PubMed  Google Scholar 

  12. Shau H, Kim A (1994) Identification of natural killer enhancing factor as a major antioxidant in human red blood cells. Biochem Biophys Res Commun 199:83–88

    Article  CAS  PubMed  Google Scholar 

  13. Netto LE, Kowaltowski AJ, Castilho RF et al (2002) Thiol enzymes protecting mitochondria against oxidative damage. Methods Enzymol 348:260–270

    Article  CAS  PubMed  Google Scholar 

  14. Zhang P, Liu B, Kang SW et al (1997) Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2. J Biol Chem 272:30615–30618

    Article  CAS  PubMed  Google Scholar 

  15. Park SH, Chung YM, Lee YS et al (2000) Antisense of human peroxiredoxin II enhances radiation-induced cell death. Clin Cancer Res 6:4915–4920

    CAS  PubMed  Google Scholar 

  16. Yoo YD, Chung YM, Park JK et al (2002) Synergistic effect of peroxiredoxin II antisense on cisplatin-induced cell death. Exp Mol Med 34:273–277

    Article  CAS  Google Scholar 

  17. Kim H, Lee TH, Park ES et al (2000) Role of peroxideroxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells. J Biol Chem 275:18266–18270

    Article  CAS  PubMed  Google Scholar 

  18. Zhao Fang, Wang Qinghua (2012) The protective effect of peroxiredoxin II on oxidative stress induced apoptosis in pancreatic β-cells. Cell Biosci 2(1):22

    Article  PubMed Central  PubMed  Google Scholar 

  19. Lim MJ, Chae HZ, Rhee SG et al (1998) The type II peroxiredoxin gene family of the mouse: molecular structure, expression and evolution. Gene 216:197–205

    Article  CAS  PubMed  Google Scholar 

  20. Noh DY, Ahn SJ, Lee RA et al (2001) Overexpression of peroxiredoxin in human breast cancer. Anticancer Res 21:2085–2090

    CAS  PubMed  Google Scholar 

  21. Wu XY, Fu ZX, Wang XH (2010) Peroxiredoxins in colorectal neoplasms. Histol Histopathol 25:1297–1303

    CAS  PubMed  Google Scholar 

  22. Kang SW, Chae HZ, Seo MS et al (1998) Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J Biol Chem 273:6297–6302

    Article  CAS  PubMed  Google Scholar 

  23. Qu D, Rashidian J, Mount MP et al (2007) Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson’s disease. Neuron 55:37–52

    Article  CAS  PubMed  Google Scholar 

  24. Yang S, Luo A, Hao X et al (2011) Peroxiredoxin 2 inhibits granulosa cell apoptosis during follicle atresia through the NFKB pathway in mice. Biol Reprod 84(6):1182–1189

    Article  CAS  PubMed  Google Scholar 

  25. Brunelle JK, Letai A (2009) Control of mitochondrial apoptosis by the Bcl-2 family. J Cell Sci 122:437–441

    Article  CAS  PubMed  Google Scholar 

  26. Fulda S (2010) Exploiting mitochondrial apoptosis for the treatment of cancer. Mitochondrion 10:598–603

    Article  CAS  PubMed  Google Scholar 

  27. Yang C, Liu HZ, Fu ZX (2012) Effects of PEG-liposomal oxaliplatin on apoptosis, and expression of cyclin A and cyclin D1 in colorectal cancer cells. Oncol Rep 28(3):1006–1012

    CAS  PubMed  Google Scholar 

  28. Luo X, Budihardjo I, Zou H et al (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481–490

    Article  CAS  PubMed  Google Scholar 

  29. Walters J, Pop C, Scott FL et al (2009) A constitutively active and uninhibitable caspase-3 zymogen efficiently induces apoptosis. Biochem J 424:335–345

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Janicke RU, Sprengart ML, Wati MR, Porter AG (1998) Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273:9357–9360

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

This study was supported by a Grant from the National Natural Science Foundation of China (No. 81172295).

Conflict of interest

The authors have no financial or other conflicts of interest with regard to this work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhongxue Fu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lu, W., Fu, Z., Wang, H. et al. Peroxiredoxin 2 is upregulated in colorectal cancer and contributes to colorectal cancer cells’ survival by protecting cells from oxidative stress. Mol Cell Biochem 387, 261–270 (2014). https://doi.org/10.1007/s11010-013-1891-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-013-1891-4

Keywords

Navigation